Annual Working Capital
$1.84 M
-$1.78 M-49.16%
31 December 2023
Summary:
XTL Biopharmaceuticals annual working capital is currently $1.84 million, with the most recent change of -$1.78 million (-49.16%) on 31 December 2023. During the last 3 years, it has fallen by -$4.03 million (-68.64%). XTLB annual working capital is now -91.89% below its all-time high of $22.69 million, reached on 31 December 2006.XTLB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$2.33 M
+$485.00 K+26.36%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly working capital is currently $2.33 million, with the most recent change of +$485.00 thousand (+26.36%) on 31 March 2024. Over the past year, it has increased by +$204.00 thousand (+9.62%). XTLB quarterly working capital is now -92.17% below its all-time high of $29.71 million, reached on 30 June 2006.XTLB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.2% | +9.6% |
| 3 y3 years | -68.6% | -63.0% |
| 5 y5 years | -76.8% | -69.8% |
XTLB Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -69.4% | at low | -63.0% | +26.4% |
| 5 y | 5 years | -76.8% | at low | -69.8% | +26.4% |
| alltime | all time | -91.9% | at low | -92.2% | +438.9% |
XTL Biopharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $2.33 M(+26.4%) |
| Dec 2023 | $1.84 M(-49.2%) | $1.84 M(-13.2%) |
| Sept 2023 | - | $2.12 M(-9.3%) |
| June 2023 | - | $2.34 M(-13.4%) |
| Mar 2023 | - | $2.70 M(-25.4%) |
| Dec 2022 | $3.62 M(-39.7%) | $3.62 M(-17.1%) |
| Sept 2022 | - | $4.36 M(-16.1%) |
| June 2022 | - | $5.20 M(-13.0%) |
| Mar 2022 | - | $5.98 M(-0.4%) |
| Dec 2021 | $6.01 M(+2.4%) | $6.01 M(-4.5%) |
| Sept 2021 | - | $6.29 M(-0.4%) |
| June 2021 | - | $6.31 M(-5.5%) |
| Mar 2021 | - | $6.68 M(+13.8%) |
| Dec 2020 | $5.87 M(-11.1%) | $5.87 M(+3.9%) |
| Sept 2020 | - | $5.65 M(-9.1%) |
| June 2020 | - | $6.21 M(-6.5%) |
| Mar 2020 | - | $6.64 M(+0.7%) |
| Dec 2019 | $6.60 M(-16.9%) | $6.60 M(-14.4%) |
| Sept 2019 | - | $7.71 M(-14.0%) |
| June 2019 | - | $8.96 M(-24.1%) |
| Mar 2019 | - | $11.82 M(+48.8%) |
| Dec 2018 | $7.94 M(+34.5%) | $7.94 M(+15.2%) |
| Sept 2018 | - | $6.89 M(+17.7%) |
| June 2018 | - | $5.86 M(+0.7%) |
| Mar 2018 | - | $5.82 M(-1.5%) |
| Dec 2017 | $5.91 M(+143.6%) | $5.91 M(-4.1%) |
| Sept 2017 | - | $6.16 M(-3.9%) |
| June 2017 | - | $6.41 M(-6.6%) |
| Mar 2017 | - | $6.86 M(+183.1%) |
| Dec 2016 | $2.42 M(-36.7%) | $2.42 M(-18.1%) |
| June 2016 | - | $2.96 M(-22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $3.83 M(+79.3%) | $3.83 M(-16.0%) |
| Sept 2015 | - | $4.56 M(-9.4%) |
| June 2015 | - | $5.03 M(+135.3%) |
| Dec 2014 | $2.14 M(-44.8%) | $2.14 M(-21.3%) |
| Sept 2014 | - | $2.71 M(-11.7%) |
| June 2014 | - | $3.08 M(-11.7%) |
| Mar 2014 | - | $3.48 M(-9.9%) |
| Dec 2013 | $3.87 M(+80.6%) | $3.87 M(-9.2%) |
| Sept 2013 | - | $4.26 M(+244.7%) |
| June 2013 | - | $1.24 M(-29.3%) |
| Mar 2013 | - | $1.75 M(-18.4%) |
| Dec 2012 | $2.14 M(-74.9%) | $2.14 M(-20.5%) |
| Sept 2012 | - | $2.69 M(-3.3%) |
| June 2012 | - | $2.79 M(-9.9%) |
| Mar 2012 | - | $3.09 M(+154.1%) |
| Sept 2011 | - | $1.22 M(-19.4%) |
| June 2011 | - | $1.51 M(-13.5%) |
| Mar 2011 | - | $1.75 M(+242.8%) |
| Sept 2010 | - | $509.00 K(-174.2%) |
| June 2010 | - | -$686.00 K(+72.4%) |
| Mar 2010 | - | -$398.00 K(-443.1%) |
| Sept 2009 | - | $116.00 K(-95.6%) |
| June 2008 | - | $2.66 M(-68.8%) |
| Dec 2007 | $8.53 M(-62.4%) | $8.53 M(-7.5%) |
| June 2007 | - | $9.23 M(-59.3%) |
| Dec 2006 | $22.69 M(+99.3%) | $22.69 M(-23.6%) |
| June 2006 | - | $29.71 M(+161.0%) |
| Dec 2005 | $11.38 M(-43.8%) | $11.38 M(-26.7%) |
| June 2005 | - | $15.53 M(-23.3%) |
| Dec 2004 | $20.24 M(+1.4%) | $20.24 M(+90.4%) |
| June 2004 | - | $10.63 M |
| Dec 2003 | $19.97 M | - |
FAQ
- What is XTL Biopharmaceuticals annual working capital?
- What is the all time high annual working capital for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual working capital year-on-year change?
- What is XTL Biopharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly working capital year-on-year change?
What is XTL Biopharmaceuticals annual working capital?
The current annual working capital of XTLB is $1.84 M
What is the all time high annual working capital for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual working capital is $22.69 M
What is XTL Biopharmaceuticals annual working capital year-on-year change?
Over the past year, XTLB annual working capital has changed by -$1.78 M (-49.16%)
What is XTL Biopharmaceuticals quarterly working capital?
The current quarterly working capital of XTLB is $2.33 M
What is the all time high quarterly working capital for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly working capital is $29.71 M
What is XTL Biopharmaceuticals quarterly working capital year-on-year change?
Over the past year, XTLB quarterly working capital has changed by +$204.00 K (+9.62%)